BlackDiamond Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.76M Buy
6,003
+770
+15% +$197K 0.68% 39
2026
Q2
$1.3M Buy
5,233
+190
+4% +$40.9K 0.52% 51
2026
Q1
$1.1M Buy
5,043
+65
+1% +$14.4K 0.53% 48
2025
Q4
$1.11M Buy
4,978
+2,820
+131% +$642K 0.54% 49
2025
Q3
$500K Buy
2,158
+47
+2% +$9.6K 0.27% 74
2025
Q2
$401K Buy
2,111
+228
+12% +$42.4K 0.23% 83
2025
Q1
$348K Sell
1,883
-394
-17% -$76.6K 0.23% 81
2024
Q4
$405K Buy
2,277
+109
+5% +$20K 0.23% 94
2024
Q3
$371K Buy
2,168
+228
+12% +$42.6K 0.22% 101
2024
Q2
$369K Buy
1,940
+413
+27% +$68.4K 0.24% 91
2024
Q1
$278K Sell
1,527
-24
-2% -$4.14K 0.2% 114
2023
Q4
$266K Buy
+1,551
New +$226K 0.2% 110
2023
Q2
– Sell
-1,287
Closed -$212K – 129
2023
Q1
$212K Buy
1,287
+20
+2% +$3.06K 0.22% 104
2022
Q4
$202K Buy
+1,267
New +$194K 0.23% 108

Other funds holding ABBV

BlackDiamond Wealth Management's ABBV Position: Q3 2026 in Review

BlackDiamond Wealth Management increased its AbbVie (ABBV) stake by 15% in Q3 2026, buying an estimated $197K and bringing the position to 6,003 shares worth $1.76M. The position accounts for 0.68% of the portfolio, ranked #39.

BlackDiamond Wealth Management first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. 4,228 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • BlackDiamond Wealth Management held 6,003 shares of AbbVie worth $1.76M as of Q3 2026.
  • BlackDiamond Wealth Management bought 770 AbbVie shares in Q3 2026, an estimated $197K.
  • AbbVie made up 0.68% of BlackDiamond Wealth Management's portfolio in Q3 2026, its #39 holding.
  • BlackDiamond Wealth Management first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
  • 4,228 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on BlackDiamond Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.